Corbus Pharmaceuticals (CRBP) Short Interest Ratio & Short Volume → “Crash Insurance” For Your Retirement (From Unstoppable Prosperity) (Ad) Free CRBP Stock Alerts $43.55 -0.19 (-0.43%) (As of 09:30 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Corbus Pharmaceuticals Short Interest DataCurrent Short Volume710,700 sharesPrevious Short Volume623,100 sharesChange Vs. Previous Month+14.06%Dollar Volume Sold Short$26.32 millionShort Interest Ratio / Days to Cover2.5Last Record DateApril 30, 2024Outstanding Shares10,507,000 sharesFloat Size10,390,000 sharesShort Percent of Float6.84%Today's Trading Volume1,811 sharesAverage Trading Volume713,503 sharesToday's Volume Vs. Average0% Short Selling Corbus Pharmaceuticals ? Sign up to receive the latest short interest report for Corbus Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCRBP Short Interest Over TimeCRBP Days to Cover Over TimeCRBP Percentage of Float Shorted Over Time Ad Manward PressShocking: One AI startup's revenue could surge 4,735%Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner.Click here to discover the AI chip company Corbus Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024710,700 shares $26.32 million +14.1%6.8%2.5 $37.04 4/15/2024623,100 shares $26.62 million +31.0%6.0%0.7 $42.72 3/31/2024475,600 shares $18.66 million +17.8%4.6%0.5 $39.24 3/15/2024403,800 shares $17.64 million +560.9%3.9%0.5 $43.68 2/29/202461,100 shares $1.89 million -34.2%0.6%0.1 $30.90 2/15/202492,900 shares $2.09 million -80.0%0.9%0.1 $22.48 Get the Latest News and Ratings for CRBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Corbus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024464,700 shares $12.31 million +1,553.7%4.5%0.6 $26.49 1/15/202428,100 shares $166,633.00 -29.4%0.6%1.2 $5.93 12/31/202339,800 shares $240,392.00 -16.4%0.9%2.2 $6.04 12/15/202347,600 shares $261,800.00 +4.6%1.1%3.1 $5.50 11/30/202345,500 shares $304,395.00 -19.8%1.0%3.4 $6.69 11/15/202356,700 shares $255,717.00 +3.3%1.3%4.7 $4.51 10/31/202354,900 shares $299,205.00 -11.0%1.2%5.1 $5.45 10/15/202361,700 shares $372,051.00 -3.1%1.4%6.4 $6.03 9/30/202363,700 shares $429,338.00 -2.6%1.4%5.7 $6.74 9/15/202365,400 shares $459,108.00 -13.3%1.5%5.4 $7.02 8/31/202375,400 shares $550,420.00 -6.1%1.7%5.2 $7.30 8/15/202380,300 shares $514,723.00 -10.6%1.8%4.5 $6.41 7/31/202389,800 shares $646,560.00 -8.6%2.0%3.8 $7.20 7/15/202398,200 shares $753,194.00 -13.3%2.2%2.7 $7.67 6/30/2023113,300 shares $888,272.00 +0.2%2.6%2 $7.84 6/15/2023113,100 shares $876,525.00 +4.9%2.6%1.3 $7.75 5/31/2023107,800 shares $1.02 million -23.6%2.6%0.2 $9.47 5/15/2023141,100 shares $1.48 million -31.2%3.4%0.3 $10.50 4/30/2023205,100 shares $1.80 million -31.0%4.9%0.5 $8.78 4/15/2023297,200 shares $2.85 million -17.7%7.2%0.7 $9.59 3/31/2023360,900 shares $2.62 million +147.0%8.7%0.8 $7.27 3/15/2023146,100 shares $425,151.00 -1.8%3.5%0.4 $2.91 2/28/2023148,700 shares $444,613.00 +25.1%3.6%2 $2.99 2/15/2023118,900 shares $366,212.00 -96.0%2.9%0.8 $3.08 1/31/20232,960,000 shares $459,096.00 -5.4%2.4%0.7 $0.16 1/15/20233,130,000 shares $453,224.00 -15.0%2.5%0.7 $0.14 12/30/20223,680,000 shares $406,640.00 -20.7%3.0%0.7 $0.11 12/15/20224,640,000 shares $575,360.00 +17.8%3.7%0.9 $0.12 11/30/20223,940,000 shares $766,330.00 -15.1%3.2%0.8 $0.19 11/15/20224,640,000 shares $625,472.00 -2.5%3.7%1.9 $0.13 10/31/20224,760,000 shares $618,800.00 +22.1%3.8%1.9 $0.13 10/15/20223,900,000 shares $468,000.00 +4.8%3.1%1.6 $0.12 9/30/20223,720,000 shares $613,800.00 +10.7%3.0%3.6 $0.17 9/15/20223,360,000 shares $697,536.00 -11.6%2.7%3.6 $0.21Shocking: One AI startup's revenue could surge 4,735% (Ad)Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner.Click here to discover the AI chip company CRBP Short Interest - Frequently Asked Questions What is Corbus Pharmaceuticals' current short interest? Short interest is the volume of Corbus Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 710,700 shares of CRBP short. 6.84% of Corbus Pharmaceuticals' shares are currently sold short. Learn More on Corbus Pharmaceuticals' current short interest. What is a good short interest ratio for Corbus Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRBP shares currently have a short interest ratio of 2.0. Learn More on Corbus Pharmaceuticals's short interest ratio. Which institutional investors are shorting Corbus Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Corbus Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Corbus Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.84% of Corbus Pharmaceuticals' floating shares are currently sold short. Is Corbus Pharmaceuticals' short interest increasing or decreasing? Corbus Pharmaceuticals saw a increase in short interest in April. As of April 30th, there was short interest totaling 710,700 shares, an increase of 14.1% from the previous total of 623,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Corbus Pharmaceuticals' float size? Corbus Pharmaceuticals currently has issued a total of 10,507,000 shares. Some of Corbus Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Corbus Pharmaceuticals currently has a public float of 10,390,000 shares. How does Corbus Pharmaceuticals' short interest compare to its competitors? 6.84% of Corbus Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Corbus Pharmaceuticals: Mersana Therapeutics, Inc. (8.72%), Annexon, Inc. (6.63%), Biomea Fusion, Inc. (50.32%), Heron Therapeutics, Inc. (18.12%), Korro Bio, Inc. (2.68%), Amarin Co. plc (3.94%), Lexicon Pharmaceuticals, Inc. (9.52%), ADC Therapeutics SA (1.43%), Neurogene Inc. (8.58%), Esperion Therapeutics, Inc. (11.79%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Coinbase Global, Inc. ($2.18 billion), Chesapeake Energy Co. ($1.52 billion), Carnival Co. & plc ($1.43 billion), AppLovin Co. ($1.39 billion), CarMax, Inc. ($1.34 billion), Imperial Oil Limited ($1.23 billion), Enphase Energy, Inc. ($1.22 billion), and Best Buy Co., Inc. ($1.19 billion). View all of the most shorted stocks. What does it mean to sell short Corbus Pharmaceuticals stock? Short selling CRBP is an investing strategy that aims to generate trading profit from Corbus Pharmaceuticals as its price is falling. CRBP shares are trading down $0.19 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Corbus Pharmaceuticals? A short squeeze for Corbus Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CRBP, which in turn drives the price of the stock up even further. How often is Corbus Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRBP, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: MRSN Short Interest Data ANNX Short Interest Data BMEA Short Interest Data HRTX Short Interest Data KRRO Short Interest Data AMRN Short Interest Data LXRX Short Interest Data ADCT Short Interest Data NGNE Short Interest Data ESPR Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CRBP) was last updated on 5/10/2024 by MarketBeat.com Staff From Our Partners[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICYou need to know these two things about AI stocks ASAP…InvestorPlaceThis 1 Biotech Stock has been shocking the marketsHuge AlertsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingTrump Asset Seizure Threat Alert: Could Your Savings Be Next?American Hartford Gold Group